HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Ultromics Raises $33M Series B Funding Led by Blue Venture Fund
Led by Blue Venture Fund, new funding will accelerate Ultromics' use of AI-enabled echocardiograms to improve patient outcomes.
BrainQ $40M Funding Round to Support Multicenter Pivotal Trial
The funding will be used to support a multicenter pivotal trial for its groundbreaking technology for ischemic stroke survivors in selected US hospitals.
HAGAR Secures $11.7M Series B Funding To Develop Clinical Trials
The round was led by a returning investor, Columbia Pacific. This investment brings HAGAR’s total funding to $17.1 million, following the $4.4 million in Series A funding it received in March 2021.
Append Medical Completes $7.4M Million Series A Round
Funding will support the company’s first clinical trial on its path to regulatory clearance.
MiRus™ Raises $65 Million For Expansion of Rhenium-based Medical Devices
MiRus spine implants are distributed through leading hospitals and surgery centers around the country.
Biospectal Raises $4.3M Seed Funding Led by Digital Health Investor, SeedLink
“Biospectal OptiBP is a breakthrough technology that enables more accessible, effective, and efficient patient monitoring to empower patients to contribute to, and participate in, the clinical regimen for chronic condition monitoring and management,” said Tim Juergens, General Manager, and co-founder, SeedLink.
R2 Technologies Receives Series C Investment of $15 Mil
The funds will be used to expand the company’s corporate footprint and US commercial acceleration of Glacial Rx™, its first-to-market revolutionary CryoAesthetic™ treatment, FDA-cleared to remove benign lesions and temporarily reduce pain, swelling and inflammation.
BIRD Foundation- Israel-U.S. Binational Industrial R&D Foundation to Invest $6 Mil in 6 New Projects
The approved projects involve innovations in the areas of Advanced Manufacturing, Communications, Cyber Security, Healthcare IT, Medical Devices, and others.
Sweetch Secures $20 Million Series A to Accelerate Fully Automated Hyper-Personalized Engagement Between Health Ecosystem Players and People with Chronic Conditions
The Series A was led by Entrée Capital. It was joined by Tal Capital, Netherlands-based impact investor Noaber, Brazil-based Kortex Ventures, and Insurtech VC FinTLV Ventures, as well as existing investors Philips, OurCrowd and Qure Ventures.
